cbst

Cubist Announces EMA Acceptance of Tedizolid Marketing Authorization Application for Review

[at noodls] – LEXINGTON, Mass.–(BUSINESS WIRE)– Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the European Medicines Agency (EMA) has accepted for review the Company’s Marketing Authorization Application … moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]

Cubist & Cambridge Science Festival Launch “Germ Challenge” Science Contest

[Business Wire] – Cambridge Science Festival and Cubist Pharmaceuticals, Inc. today launched the 2014 “Germ Challenge,” a contest designed to engage young people in science by inviting them to create educational and creative videos that demonstrate t moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click […]

Two Stocks I'm Watching Right Now — Trading Concepts | E-Mini …

On today’s video I talk about the stock Cubist Pharmaceuticals (CBST) and NexEra Energy (NEE) – they may be setting up for nice long plays so be sure to watch the video.Also be sure to watch Doc’s 13 minute video where he explains a new type of options trade:

Source: 

Two Stocks I'm Watching Right Now — Trading Concepts | E-Mini …
 […]

Cubist Obtains Remaining Rights to Ceftolozane from Astellas

[Business Wire] – LEXINGTON, Mass. & TOKYO–(BUSINESSWIRE)– Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) and Astellas Pharma Inc. (Tokyo: 4503) today announced that they entered into an agreement under which Cubist obtains … moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]